Stay updated on Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page.

Latest updates to the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedMajor changes: version updated to v3.2.0 and a prominent notice about government funding and operating status. Removed reference to v3.1.0.SummaryDifference4%

- Check26 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

- Check40 days agoChange DetectedUpdated page metadata to revision v3.0.2 with September 2025 date stamps and an estimated Last Update Posted. Removed older date stamps (and the prior v3.0.1 revision) and the Back to Top link.SummaryDifference0.9%

- Check48 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%

- Check55 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as a range of new medical terms related to proteins and therapeutics. Notably, the revision number has been updated to v3.0.0, indicating a major change.SummaryDifference3%

- Check69 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%

Stay in the know with updates to Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page.